These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1507377)

  • 1. Prescription drug diversion control and medical practice.
    Cooper JR; Czechowicz DJ; Petersen RC; Molinari SP
    JAMA; 1992 Sep; 268(10):1306-10. PubMed ID: 1507377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential.
    Simoni-Wastila L; Tompkins C
    Subst Use Misuse; 2001; 36(9-10):1275-96. PubMed ID: 11592473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PADS approach to preventing prescription drug diversion.
    Ambre JJ
    NIDA Res Monogr; 1993; 131():141-4. PubMed ID: 8413524
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription drug diversion: "what Lola wants, Lola gets".
    Thomison JB
    J Tenn Med Assoc; 1989 Jan; 82(1):35-7. PubMed ID: 2927111
    [No Abstract]   [Full Text] [Related]  

  • 5. An American Medical Association perspective on preventing prescription drug diversion.
    Ambre JJ
    NIDA Res Monogr; 1993; 131():224-7. PubMed ID: 8413533
    [No Abstract]   [Full Text] [Related]  

  • 6. Is the DEA's new "prescription series" regulation balanced?
    Gilson AM; Joranson DE
    J Pain Palliat Care Pharmacother; 2008; 22(3):218-20. PubMed ID: 19042852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances.
    Joranson DE
    NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain.
    Fishman SM; Papazian JS; Gonzalez S; Riches PS; Gilson A
    Pain Med; 2004 Sep; 5(3):309-24. PubMed ID: 15367312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug diversion control systems, medical practice, and patient care.
    Haislip GR
    NIDA Res Monogr; 1993; 131():120-31. PubMed ID: 8413522
    [No Abstract]   [Full Text] [Related]  

  • 10. The Illinois experience in achieving the medical/regulatory balance required to control prescription drug diversion.
    Bishop MT; Vlasty RJ
    NIDA Res Monogr; 1993; 131():159-75. PubMed ID: 8413527
    [No Abstract]   [Full Text] [Related]  

  • 11. Can drug design inhibit abuse?
    Coleman JJ; Bensinger PB; Gold MS; Smith DE; Bianchi RP; DuPont RL
    J Psychoactive Drugs; 2005 Dec; 37(4):343-62. PubMed ID: 16480162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEA physician registration numbers: a need to know.
    Cooper JR
    JAMA; 1994 Jan; 271(3):193-4. PubMed ID: 8277541
    [No Abstract]   [Full Text] [Related]  

  • 13. An empirical review of the impact of triplicate prescription of benzodiazepines.
    Schwartz HI
    Hosp Community Psychiatry; 1992 Apr; 43(4):382-5. PubMed ID: 1349557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Minnesota Prescription Monitoring Program.
    Herman C
    Northwest Dent; 2011; 90(2):33-5. PubMed ID: 21667591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of prescription drug diversion control systems on medical practice and patient care. Technical review, May 30-June 1, 1991. Proceedings.
    NIDA Res Monogr; 1993; 131():1-334. PubMed ID: 8413520
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing issues grant report to the Board of Medical Examiners. II. Minnesota Medical Association.
    Minn Med; 1990 Aug; 73(8):36-42. PubMed ID: 2398844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in opioid analgesic abuse and mortality in the United States.
    Dart RC; Surratt HL; Cicero TJ; Parrino MW; Severtson SG; Bucher-Bartelson B; Green JL
    N Engl J Med; 2015 Jan; 372(3):241-8. PubMed ID: 25587948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician perspectives on a pilot prescription monitoring program.
    Barrett K; Watson A
    J Pain Palliat Care Pharmacother; 2005; 19(3):5-13. PubMed ID: 16219606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research.
    Worley J
    Issues Ment Health Nurs; 2012 May; 33(5):319-28. PubMed ID: 22545639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.